Cargando…

Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents

Phosphatidylinostitol-3-kinase (PI3K) is the potential anticancer target in the PI3K/Akt/ mTOR pathway. Here we reviewed the ATP-competitive small molecule PI3K inhibitors in the past few years, including the pan Class I PI3K inhibitors, the isoform-specific PI3K inhibitors and/or the PI3K/mTOR dual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu, Wan, Wen-zhu, Li, Yan, Zhou, Guan-lian, Liu, Xin-guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351699/ https://www.ncbi.nlm.nih.gov/pubmed/27769061 http://dx.doi.org/10.18632/oncotarget.12742

Ejemplares similares

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
por: Hardianto, Ari, et al.
Publicado: (2017)

Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
por: Shetu, Shaila A., et al.
Publicado: (2022)

Structural analysis of PIM1 kinase complexes with ATP-competitive inhibitors
por: Bogusz, Jozefina, et al.
Publicado: (2017)

Divergent Modulation of Src-Family Kinase Regulatory Interactions with ATP-Competitive Inhibitors
por: Leonard, Stephen E., et al.
Publicado: (2014)

Editorial: Recent advances in the research and development of kinase-inhibitory anticancer molecules
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023)

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
por: Zhang, Qian, et al.
Publicado: (2020)

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
por: Li, Linfeng, et al.
Publicado: (2014)

Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling
por: Zhang, Haofan, et al.
Publicado: (2023)

ATP Competitive Protein Kinase C Inhibitors Demonstrate Distinct State-Dependent Inhibition
por: Smith, Ida M., et al.
Publicado: (2011)

A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties
por: Pitman, Melissa R., et al.
Publicado: (2015)

Novel non-ATP competitive small molecules targeting the CK2 α/β interface
por: Brear, Paul, et al.
Publicado: (2018)

Inhibitors in AKTion: ATP-competitive vs allosteric
por: Lazaro, Glorianne, et al.
Publicado: (2020)

Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
por: Wong, Margaret L., et al.
Publicado: (2017)

Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021)

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
por: Wang, Yi-Jun, et al.
Publicado: (2014)

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
por: Bansal, Isha, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents
por: Pla-López, Alberto, et al.
Publicado: (2022)

Imidazolylpyrrolone‐Based Small Molecules as Anticancer Agents for Renal Cell Carcinoma
por: Sousa, Ana, et al.
Publicado: (2022)

Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer
por: Kwon, Ahreum, et al.
Publicado: (2020)

Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
por: Lin, Jianjing, et al.
Publicado: (2023)

ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy
por: Olivieri, Cristina, et al.
Publicado: (2022)

Benzothiazole and Chromone Derivatives as Potential ATR Kinase Inhibitors and Anticancer Agents
por: Frasinyuk, Mykhaylo, et al.
Publicado: (2022)

Decoding kinase-adverse event associations for small molecule kinase inhibitors
por: Gong, Xiajing, et al.
Publicado: (2022)

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
por: Jiang, Tingting, et al.
Publicado: (2021)

Small-Molecule Poly(ADP-ribose) Polymerase and PD-L1 Inhibitor Conjugates as Dual-Action Anticancer Agents
por: Ofori, Samuel, et al.
Publicado: (2019)

Survivin Small Molecules Inhibitors: Recent Advances and Challenges
por: Albadari, Najah, et al.
Publicado: (2023)

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
por: Moccia, Marialuisa, et al.
Publicado: (2015)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)

An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors
por: Moolman, Chantalle, et al.
Publicado: (2020)

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
por: Viganò, Mauro, et al.
Publicado: (2023)

Rational Design and Synthesis of D‐galactosyl Lysophospholipids as Selective Substrates and non‐ATP‐competitive Inhibitors of Phosphatidylinositol Phosphate Kinases
por: Sun, Mengxia, et al.
Publicado: (2022)

Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib
por: van der Veen, Lars, et al.
Publicado: (2023)

Recent Advances in the Application of Cucurbitacins as Anticancer Agents
por: Zieniuk, Bartłomiej, et al.
Publicado: (2023)

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
por: Wu, Jianzhang, et al.
Publicado: (2015)

Anticancer activity of a novel small molecule tubulin inhibitor STK899704
por: Sakchaisri, Krisada, et al.
Publicado: (2017)

Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2
por: Anderson, Jake W., et al.
Publicado: (2023)

Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
por: Martínez, Regina, et al.
Publicado: (2020)

Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes
por: Savva, Loukiani, et al.
Publicado: (2021)

Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
por: Michaelides, Iacovos N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bfg28nffolj71thi7v5abdcc3g